Related Experiment Video
Updated: May 26, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
APOBEC3-mediated editing in HIV type 1 from pediatric patients and its association with APOBEC3G/CUL5 polymorphisms
Federico A De Maio1, Carlos A Rocco, Paula C Aulicino
1Laboratorio de Biología Celular y Retrovirus-CONICET, Hospital de Pediatría Prof. Dr. Juan P. Garrahan, Ciudad de Buenos Aires, Argentina.
Insights
APOBEC3-mediated editing of HIV-1 DNA, which can impact viral mutation and diversification, was analyzed in children. Host and viral genetic factors, not APOBEC3 activity, influenced editing levels and HIV-1 progression.
Area of Science:
- Virology
- Immunology
- Genetics
Background:
- APOBEC3 proteins are cytidine deaminases that induce G→A mutations in HIV-1 DNA.
- HIV-1 Vif protein counteracts APOBEC3 by targeting them for proteasomal degradation via a CUL5-based ubiquitin ligase complex.
- APOBEC3 editing can inhibit HIV-1 replication through hypermutation or drive viral diversification and escape variants.
Purpose of the Study:
- To analyze APOBEC3-mediated editing in perinatally HIV-1 infected children.
- To explore associations between APOBEC3 editing, host genetic polymorphisms (APOBEC3G, CUL5), HIV-1 Vif variability, and time to AIDS development.
- To develop a novel index for quantifying APOBEC3 editing levels in HIV-1 proviral DNA.
Main Methods:
- Analysis of proviral HIV-1 DNA from 93 perinatally infected children.
- Genotyping of APOBEC3G and CUL5 gene polymorphisms (APOBEC3G H186R, APOBEC3G C40693T, CUL5 SNP6).
- Sequencing of HIV-1 Vif gene variants.
- Development of a quantitative index for APOBEC3 editing using the HIV-1 pol gene's central polypurine tract (cPPT).
Main Results:
- Reduced APOBEC3-mediated editing was associated with the CUL5 SNP6 minor allele.
- Specific HIV-1 Vif variants (mutations at sites 46, 122, and 160) correlated with reduced editing.
- No significant impact of APOBEC3 activity on disease progression (time to AIDS) was detected.
Conclusions:
- APOBEC3-mediated editing of HIV-1 in pediatric infections is modulated by host (CUL5) and viral (Vif) genetic factors.
- The findings suggest complex interactions influencing viral evolution and pathogenesis in children.
- Further research is needed to fully elucidate the interplay between host genetics, viral factors, and APOBEC3 editing in HIV-1 infection.
Abstract:
The APOBEC3 proteins are cytidine deaminases that can introduce G→A mutations in the HIV-1 plus DNA strand. This editing process may inhibit virus replication through lethal mutagenesis (hypermutation), but could also contribute to viral diversification leading to the emergence of escape forms. The HIV-1 Vif protein has the capacity to counteract APOBEC3 factors by recruiting a CUL5-based ubiquitin ligase complex that determines their proteasomal degradation. In this work, we analyzed the APOBEC3-mediated editing in proviral HIV-1 from perinatally infected children (n=93) in order to explore its association with polymorphisms of APOBEC3G and CUL5 genes (APOBEC3G H186R, APOBEC3G C40693T, and CUL5 SNP6), the Vif protein variability, and also the time to AIDS development. To calculate the level of editing, we have developed an index exploiting the properties of a region within the HIV-1 pol gene that includes the central polypurine tract (cPPT). We detected a reduced editing associated with the CUL5 SNP6 minor allele and also with certain Vif variants (mutations at sites 46, 122, and 160), although we found no evidence supporting an impact of APOBEC3 activity on disease progression. Thus, our findings suggest that APOBEC3-mediated editing of HIV-1 could be modulated by host and virus genetic characteristics in the context of pediatric infection.
More Related Videos
Related Concept Videos
Viral Mutations
Retroviruses
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Cytomegalovirus Disease
RNA Editing

